Glenmark's Ryaltris Nasal Spray Now Approved in Europe
2021-4-26u2002·u2002Glenmark has received an upfront payment and will additionally receive launch & sales based milestone payments from Menarini for Ryaltris® sales. Ryaltris®, developed by Glenmark, is a novel fixed - dose combination nasal spray of an anti-histamine and a steroid, indicated for treatment of symptoms associated with allergic rhinitis (AR) in ...
Get Price